https://www.alnylam.com/
The Leading RNAi Therapeutics Company | Alnylam
Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational...
leadingrnaitherapeuticscompanyalnylam
https://www.rnaiscience.com/
Alnylam Medical Information for US Healthcare Professionals | Alnylam RNAi Science - US
us healthcare professionalsmedical informationalnylamrnaiscience
https://www.alnylam.com.br/
Alnylam® Pharmaceuticals | Principal Empresa de Terapia de RNAi | Brasil
A Alnylam está liderando a tradução da Interferência de RNA (RNAi) em uma classe de medicamentos totalmente inovadora, que acreditamos ter o potencial de...
pharmaceuticalsprincipalempresadeterapia
https://www.alnylam.ca/
Alnylam® Pharmaceuticals—The Leading RNAi Therapeutics Company | Canada
Alnylam is leading the translation of RNA interference (RNAi) into a innovative, entirely new class of medicines which we believe have the potential to...
leadingrnaitherapeuticscompanycanada
https://cordis.europa.eu/article/id/113333-engineered-adenovirus-armed-with-specific-rnai-networks-kills-selectively-tumor-cells
Engineered adenovirus armed with specific RNAi networks kills selectively tumor cells | News |...
p53, the so-called "guardian of the genome", is the most commonly dysfunctional gene in human cancers, due to mutations in the gene...
https://www.rnaiscience.com/congresses-publications/american-association-study-liver-diseases-AASLD-2025
American Association for the Study of Liver Diseases (AASLD) 2025 | Alnylam RNAi Science - US
American Association for the Study of Liver Diseases (AASLD) 2025 | Washington, D.C. . Please view American Association for the Study of Liver Diseases (AASLD)...
https://ssbd.riken.jp/database/dataset/203/
SSBD - SSBD:database - RNAi_T12D8.6_071101_01
databasernai
https://www.biotechsnap.com/p/novartis-rnai-argo-deal
Novartis doubles down on RNAi heart drugs with $160M Argo deal
Novartis expands RNAi cardiovascular strategy with $160M Argo deal, targeting innovative gene-silencing therapies to transform heart disease treatment globally.
novartisdoublesrnai
https://library.rvc.ac.uk/GroupedWork/365112dd-3162-66fe-b83e-c820e5e9ce6d-eng/Home
RNAi for plant improvement and protection | Royal Veterinary College
This book contains a series of chapters reviewing the current scientific knowledge on RNAi, methods for developing RNAi systems in transgenic plants and a...
for plantrnaiimprovementprotectionroyal
https://medicaex.com/prnewswire/sirnaomics-dosed-the-first-patient-in-phase-i-clinical-study-of-galnac-based-rnai-therapeutic-stp122g-for-anticoagulant-treatment/
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic...
Jun 2, 2023 - HONG KONG, Germantown, Md. and Suzhou, China, June 2, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the "Group" or
https://www.consultantlive.com/view/zilebesiran-rnai-for-hypertension-heads-to-phase-3-cardiovascular-outcomes-trial
Zilebesiran, RNAi for Hypertension, Heads to Phase 3 Cardiovascular Outcomes Trial
Alnylam Pharmaceuticals debuts phase 2 KARDIA-3 data at ESC 2025 and advances zilebesiran into a phase 3 outcomes trial.
zilebesiranrnaihypertensionheads
https://research-portal.uu.nl/en/activities/rnai-based-silencing-in-fungi-3/
RNAi-based silencing in Fungi - Utrecht University
rnaibasedsilencingfungiutrecht
https://www.proteinspire.org/shop/abm-ls410336-2010111i01rik-set-sirna-shrna-rnai-lentivector-mouse-39212
2010111I01Rik-set siRNA/shRNA/RNAi Lentivector (Mouse) | anticorps
setsirnashrnarnailentivector
https://rnaibased-therapeutics.com/speaker/andrew-fraley/
Andrew Fraley - 7th RNAi-Based Therapeutics Summit
Jan 22, 2026 - Andrew Fraley is the Founding and Managing Partner of Sunrise BioVentures. A prolific company builder, he is a serial entrepreneur and scientific innovator...
andrewrnaibasedtherapeuticssummit
https://armatusbio.com/
Armatus | Vectorized RNAi for rare neuromuscular disease
Armatus Bio is raising expectations for FSHD with precision gene therapy.
rare neuromusculararmatusvectorizedrnaidisease
https://www.frontiersin.org/research-topics/70314/25-year-anniversary-of-rnai-for-pest-management-milestones-and-prospects/articles
Frontiers | 25-Year Anniversary of RNAi for Pest Management: Milestones and Prospects
Over 25 years have elapsed since gene regulation by RNA interference (RNAi) was described by Fire and Mello. During this time mechanisms of RNAi were defined...
https://rnaibased-therapeutics.com/
Home - 7th RNAi-Based Therapeutics Summit
The 7th RNAi-Based Therapeutics Summit is the only event uniting the RNA interference ecosystem to translate the next wave of siRNA and microRNA drugs
rnaibasedtherapeuticssummit
https://www.sigmaaldrich.com/DK/en/products/molecular-biology-and-functional-genomics/gene-editing-and-functional-genomics/rnai-single-clones
RNAi Single Clones
Genome-wide human and mouse shRNA clones from the TRC1.5 and TRC2 collections, available as plasmids or high-titer virus.
rnaisingleclones
https://oligotherapeutics.org/galnac-sirna-conjugates-leading-the-way-for-delivery-of-rnai-therapeutics/
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics - Oligonucleotide...
Nov 8, 2021 - Springer AD, Dowdy SF. Nucleic Acid Ther. 2018 Jun;28(3):109-118. PubMed
leading the way
https://www.proteinspire.org/shop/abm-ls410164-1700016h13rik-set-sirna-shrna-rnai-lentivector-mouse-37482
1700016H13Rik-set siRNA/shRNA/RNAi Lentivector (Mouse) | anticorps
setsirnashrnarnailentivector
https://www.origene.com/
Validated Antibodies, cDNA Clones, Lentivirus, RNAi | OriGene Technologies Inc.
OriGene is a global leader in providing high-quality reagents to support genomic and proteomic research, including cDNA clones, antibodies, recombinant...
cdna clonesorigene technologiesvalidatedantibodieslentivirus
https://pubchem.ncbi.nlm.nih.gov/bioassay/1671195
AID 1671195 - Genome-wide RNAi Screen for Regulators of LDLR Activity - PubChem
BioAssay record AID 1671195 submitted by Fernandez-Hernando Lab, Department of Comparative Medicine, Yale University: Genome-wide RNAi Screen for Regulators of...
https://edoc.mdc-berlin.de/id/eprint/14022/
An RNAi-based approach to down-regulate a gene family in vivo - MDC Repository
https://curf.clemson.edu/technology/fusogenic-peptides-for-delivery-of-rnai-therapeutics-to-ovarian-cancer-2/
Fusogenic Peptides for Ovarian Cancer RNAi Therapy - CURF
Mar 27, 2026 - Innovative fusogenic peptides enhance RNAi therapy delivery, improving targeted ovarian cancer treatment for greater efficacy and precision.
ovarian cancerpeptidesrnaitherapy
https://www.biologicspd.com/shop/fm-13778150-lipofectamine-rnai-max-11919?category=36
Lipofectamine RNAi MAX | Biologic Process Development
rnaimaxbiologicprocessdevelopment
https://iris.uniupo.it/handle/11579/19979
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated...
https://www.switchthera.com/
Revolutionizing RNAi Therapies | Switch Therapeutics
Apr 8, 2025 - Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
revolutionizingrnaitherapiesswitchtherapeutics
https://data.rnaiscience.com/congresses/pediatric-academic-societies-2026?site=us
PAS 2026: Pediatric Academic Societies | Alnylam RNAi Science Data Hall
Pediatric Academic Societies 2026 | Boston, MA, USA. View selected Alnylam scientific information presented at PAS 2026. Connect with Alnylam Medical...
academic societiesscience datapaspediatricalnylam
https://www.atopixtherapeutics.com/shop/boc-0523-10-adenovirus-cmv-rnai-51473
ADENOVIRUS-CMV-RNAI | Atopix
adenoviruscmvrnai
https://ssbd.riken.jp/database/dataset/133/
SSBD - SSBD:database - RNAi_F58A4.3_040803_02
databasernai
https://www.natap.org/2014/HBV/011315_02.htm
Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic...
https://www.protocol-online.org/biology-forums/posts/40641.html
confusion about off-target effect - siRNA, microRNA and RNAi
about offconfusiontargeteffectsirna
https://eshop.biogen.cz/kits-for-dsrnarnai-synthesis
Kits for dsRNA/RNAi Synthesis
kitsrnaisynthesis
https://pubmed.ncbi.nlm.nih.gov/41544794/
RNAi therapy targeting coronavirus genomes, pulmonary delivery strategies and design principles: A...
With the persistent global outbreak of Coronavirus Disease 2019 (COVID-19), the development of effective antiviral strategies has become a top priority in...
https://www.natap.org/2020/AASLD/AASLD_87.htm
HBV RNAi inhibitor RG6346 in Phase 1b-2a trial was safe, well-tolerated, and resulted in...
https://finviz.com/news/282211/silexion-therapeutics-to-attend-7th-annual-rnai-based-therapeutics-summit
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
Stock screener for investors and traders, financial visualizations.
to attendtherapeuticsannualrnaibased
https://www.alliedacademies.org/abstract/designer-sirnas-to-overcome-the-challenges-from-the-rnai-pathway-4424.html
Designer siRNAs to overcome the challenges from the RNAi pathway | Abstract
Small interfering RNA (siRNA)-based technology is playing a pivotal role in understanding gene function. Huge siRNA libraries coupled to high-content ..
the challengesdesignerovercomernaipathway
https://www.nature.com/articles/s41467-025-60497-8?error=cookies_not_supported&code=ad9dace4-4a2f-4020-a997-64b26e56bcc3
AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice |...
Oct 23, 2025 - Amyotrophic lateral sclerosis (ALS) involves motor neuron death due to mislocalized TDP-43. Pathologic TDP-43 associates with stress granules (SGs), and...
https://www.clinicaltrialsarena.com/events/2nd-annual-rnai-based-therapeutics-summit-june-2021-digital-event/
2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event - Clinical Trials Arena
https://www.protocol-online.org/prot/Molecular_Biology/RNA/RNA_Interference__RNAi_/index.html
RNA/RNA Interference (RNAi) Protocols
RNA interference protocols
rna interferencernaiprotocols
https://urgi.versailles.inrae.fr/faidare/studies/dXJuOkVWQS9zdHVkeS9QUkpOQTM3Mzg5MA==
Study : Gossypium hirsutum L. cv. Coker 312 phytochrome A1(PHYA1) RNAi line cotton boll total RNA
https://www.rnaiscience.com/search?query=amyloidosis&page=1
Search Medical Information & Resources | Alnylam RNAi Science - US
search medical informationresourcesalnylamrnaiscience
https://www.pfsa.be/shop/abm-ls410018-0610037l13rik-set-sirna-shrna-rnai-lentivector-mouse-36029
0610037L13Rik-set siRNA/shRNA/RNAi Lentivector (Mouse) | Plate Form SA
setsirnashrnarnailentivector
https://www.researchandmarkets.com/report/united-arab-emirates-rnai-therapy-market
United Arab Emirates RNAi Therapeutics Market Size & Trends
United Arab Emirates RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
united arab emiratesmarket sizernaitherapeuticstrends
https://www.watchacrestv.com/videos/vorceed-enlist-corn
Enlist Corn RNAi Technology | Corteva - Seed - AcresTV
Corteva Enlist corn brings a brand-new mode of action to control corn rootworm larvae in your corn while also stacking multiple new modes of action for...
enlistcornrnaitechnologycorteva
https://ssbd.riken.jp/database/dataset/246/
SSBD - SSBD:database - RNAi_Y37D8A.14_041109_02
databasernai
https://ricerca.uniba.it/handle/11586/128522
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell...
https://www.immunecentral.com/shop/171-i023308-snord116-set-sirna-shrna-rnai-lentivect-10015
SNORD116@-set siRNA/shRNA/RNAi Lentivect | Immune Central
setsirnashrnarnaiimmune
https://www.protocol-online.org/biology-forums/siRNA--microRNA-and-RNAi/more16.html
- siRNA--microRNA-and-RNAi
sirnamicrornarnai
https://www.indianperson.com/tag/antisense-rnai-therapeutics-market-future/
Antisense & RNAi Therapeutics Market future Archives - Jan Sewa
future archivesrnaitherapeuticsmarketjan
https://www.rnaiscience.com/search?query=diagnosis
Search Medical Information & Resources | Alnylam RNAi Science - US
search medical informationresourcesalnylamrnaiscience
https://www.prnewswire.com/news-releases/the-global-antisense-and-rnai-therapeutics-market-size-is-expected-to-reach-usd-1-81-billion-by-2025--300797334.html
The global antisense and RNAi therapeutics market size is expected to reach USD 1.81 billion by 2025
https://galleon-stage.synthego.com/blog/rnai-vs-crispr-guide/
RNAi vs. CRISPR: Guide to Selecting the Best Gene Silencing Method
Oct 10, 2025 - RNAi and CRISPR interrogate gene function by blocking gene expression and analyzing its effect on phenotype. RNAi silences genes by generating knockdowns at...
guide tothe bestgene silencingrnaivs
https://www.sanegenebio.com/
RNAi Therapies for Metabolic and Autoimmune Diseases
Mar 30, 2026 - Revolutionizing RNAi therapies for metabolic and autoimmune diseases through its Ligand and Enhancer Assisted (LEAD™) Technology.
rnaitherapiesmetabolicautoimmunediseases